Does PEMBROLIZUMAB Cause Muscular weakness? 561 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 561 reports of Muscular weakness have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.7% of all adverse event reports for PEMBROLIZUMAB.
561
Reports of Muscular weakness with PEMBROLIZUMAB
0.7%
of all PEMBROLIZUMAB reports
108
Deaths
322
Hospitalizations
How Dangerous Is Muscular weakness From PEMBROLIZUMAB?
Of the 561 reports, 108 (19.3%) resulted in death, 322 (57.4%) required hospitalization, and 56 (10.0%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
Yes, Muscular weakness is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which PEMBROLIZUMAB Alternatives Have Lower Muscular weakness Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G